NYSE
BHC

Bausch Health Companies Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Bausch Health Companies Inc Stock Price

Vitals

Today's Low:
$8.54
Today's High:
$8.74
Open Price:
$8.61
52W Low:
$4
52W High:
$10.23
Prev. Close:
$8.68
Volume:
1952245

Company Statistics

Market Cap.:
$2.89 billion
Book Value:
-2.2
Revenue TTM:
$8.15 billion
Operating Margin TTM:
16.92%
Gross Profit TTM:
$5.76 billion
Profit Margin:
-4.38%
Return on Assets TTM:
3.16%
Return on Equity TTM:
-17750%

Company Profile

Bausch Health Companies Inc had its IPO on 1994-03-29 under the ticker symbol BHC.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Bausch Health Companies Inc has a staff strength of 19,900 employees.

Stock update

Shares of Bausch Health Companies Inc opened at $8.61 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $8.54 - $8.74, and closed at $8.57.

This is a -1.27% slip from the previous day's closing price.

A total volume of 1,952,245 shares were traded at the close of the day’s session.

In the last one week, shares of Bausch Health Companies Inc have increased by +1.3%.

Bausch Health Companies Inc's Key Ratios

Bausch Health Companies Inc has a market cap of $2.89 billion, indicating a price to book ratio of 18.7773 and a price to sales ratio of 0.3442.

In the last 12-months Bausch Health Companies Inc’s revenue was $8.15 billion with a gross profit of $5.76 billion and an EBITDA of $2.74 billion. The EBITDA ratio measures Bausch Health Companies Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bausch Health Companies Inc’s operating margin was 16.92% while its return on assets stood at 3.16% with a return of equity of -17750%.

In Q1, Bausch Health Companies Inc’s quarterly earnings growth was a positive 111.5% while revenue growth was a positive 1.4%.

Bausch Health Companies Inc’s PE and PEG Ratio

Forward PE
2.0781
Trailing PE
0
PEG
0.6315

Its diluted EPS in the last 12-months stands at $-0.98 per share while it has a forward price to earnings multiple of 2.0781 and a PEG multiple of 0.6315. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bausch Health Companies Inc’s profitability.

Bausch Health Companies Inc stock is trading at a EV to sales ratio of 2.8975 and a EV to EBITDA ratio of 7.4851. Its price to sales ratio in the trailing 12-months stood at 0.3442.

Bausch Health Companies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$25.45 billion
Total Liabilities
$3.92 billion
Operating Cash Flow
$-78000000.00
Capital Expenditure
$51 million
Dividend Payout Ratio
0%

Bausch Health Companies Inc ended 2024 with $25.45 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $25.45 billion while shareholder equity stood at $-800000000.00.

Bausch Health Companies Inc ended 2024 with $205.00 million in deferred long-term liabilities, $3.92 billion in other current liabilities, 10405000000.00 in common stock, $-9387000000.00 in retained earnings and $11.58 billion in goodwill. Its cash balance stood at $518.00 million and cash and short-term investments were $518.00 million. The company’s total short-term debt was $446,000,000 while long-term debt stood at $20.21 billion.

Bausch Health Companies Inc’s total current assets stands at $4.24 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.69 billion compared to accounts payable of $561.00 million and inventory worth $1.22 billion.

In 2024, Bausch Health Companies Inc's operating cash flow was $-78000000.00 while its capital expenditure stood at $51 million.

Comparatively, Bausch Health Companies Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$8.57
52-Week High
$10.23
52-Week Low
$4
Analyst Target Price
$13.1

Bausch Health Companies Inc stock is currently trading at $8.57 per share. It touched a 52-week high of $10.23 and a 52-week low of $10.23. Analysts tracking the stock have a 12-month average target price of $13.1.

Its 50-day moving average was $8.7 and 200-day moving average was $7.87 The short ratio stood at 8.08 indicating a short percent outstanding of 0%.

Around 778.6% of the company’s stock are held by insiders while 8116.2% are held by institutions.

Frequently Asked Questions About Bausch Health Companies Inc

The stock symbol (also called stock or share ticker) of Bausch Health Companies Inc is BHC

The IPO of Bausch Health Companies Inc took place on 1994-03-29

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$767.35
-40.35
-5%
$0.11
-0
-3.25%
Clene Inc. (CLNN)
$0.63
-0.03
-4.39%
RARPS (RARPS)
$1.2
-1.05
-46.67%
$4.73
-0.18
-3.67%
$54.54
-2.11
-3.72%
$3.03
0.08
+2.71%
$2750.9
-129.1
-4.48%
$3.44
-0.08
-2.27%
$10.18
0.25
+2.52%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Address

2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8